Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
2.3M
-
Shares change
-
-126K
-
Total reported value, excl. options
-
$141M
-
Value change
-
-$8.02M
-
Number of buys
-
56
-
Number of sells
-
-52
-
Price
-
$61.47
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2024
129 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q4 2024.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.3M shares
of 3.2M outstanding shares and own 71.69% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (222K shares), DIMENSIONAL FUND ADVISORS LP (187K shares), VANGUARD GROUP INC (177K shares), BlackRock, Inc. (169K shares), BRANDES INVESTMENT PARTNERS, LP (163K shares), GEODE CAPITAL MANAGEMENT, LLC (97.9K shares), FMR LLC (92.4K shares), Ranger Investment Management, L.P. (84.7K shares), STATE STREET CORP (82.7K shares), and JPMORGAN CHASE & CO (79.7K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.